<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02559908</url>
  </required_header>
  <id_info>
    <org_study_id>V25L-001</org_study_id>
    <nct_id>NCT02559908</nct_id>
  </id_info>
  <brief_title>A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw</brief_title>
  <official_title>A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of VYC-25L Hyaluronic Acid Injectable Gel for Restoration and Creation of Facial Volume in the Chin and Jaw</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and performance of VYC-25L hyaluronic acid injectable gel
      for the restoration and creation of facial volume in participants seeking to increase
      projection of the chin and/or jaw.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2015</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">February 12, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in the Glabella-Subnasale-Pogonion (G-Sn-Pog) Angle</measure>
    <time_frame>Baseline, Month 3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders based on the Investigator's Assessment of Improvement in the Chin and Jaw Area using the 5-point Global Aesthetic Improvement Scale (GAIS)</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders based on the Participant's Assessment of Improvement in the Chin and Jaw Area using the 5-point GAIS</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Chin Retrusion</condition>
  <arm_group>
    <arm_group_label>Treatment Group_VYC-25L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VYC-25L injection into the chin and/or jaw areas on Day 1, volume determined by the investigator (up to 4.0 mLs) and repeat treatment if applicable</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group_No treatment then VYC-25L</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No treatment for 3 months followed by VYC-25L injection into the chin and/or jaw areas, volume determined by the investigator (up to 4.0 mLs) and repeat treatment if applicable.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hyaluronic Acid Injectable Gel</intervention_name>
    <description>Hyaluronic Acid Injectable Gel (VYC-25L) injection into the chin and/or jaw areas (up to 4.0 mLs).</description>
    <arm_group_label>Treatment Group_VYC-25L</arm_group_label>
    <arm_group_label>Control Group_No treatment then VYC-25L</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Has chin retrusion.

        Exclusion Criteria:

          -  Has ever received or is planning to receive permanent facial implants during the
             study.

          -  Has tattoos, piercings, facial hair or scars that would interfere with visual
             assessments of the chin or jaw.

          -  Has dentures or any device covering part of the palate or plans to undergo any dental
             procedure other than prophylaxis during the study.

          -  Has undergone semipermanent dermal filler treatment to the chin or jaw within 36
             months or is planning treatment during the study.

          -  Has undergone any surgery of the chin or jaw area within 24 months or a planned
             surgery during the study.

          -  Has undergone mesotherapy, cosmetic resurfacing, or botulinum toxin injections within
             6 months or a planned treatment during the study.

          -  Has experienced trauma to the chin and jaw area within 6 months.

          -  Has been previously diagnosed with streptococcal disease.

          -  Has a history of anaphylaxis or allergy to lidocaine, hyaluronic acid or streptococcal
             protein.

          -  Has porphyria or untreated epilepsy.

          -  Has active autoimmune disease.

          -  Has current cutaneous or mucosal inflammatory or infectious processes, abscess, an
             unhealed wound, or a cancerous or pre-cancerous lesion.

          -  Is on a concurrent regimen of lidocaine or structurally-related local anesthetics or
             is on a concurrent regimen of drugs that reduce or inhibit hepatic metabolism.

          -  Has impaired cardiac conduction, severely impaired hepatic function, or severe renal
             dysfunction.

          -  Is on an ongoing regimen of anti-coagulation therapy.

          -  Is on an ongoing regimen of medications (eg, aspirin, ibuprofen) or other substances
             known to increase coagulation time (eg, herbal supplements with garlic or gingko
             biloba) within the past 10 days.

          -  Has begun using any over-the-counter or prescription oral or topical, anti-wrinkle
             products below the subnasale within 30 days before enrollment or is planning to begin
             using such products during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Smita Chawla</last_name>
    <role>Study Director</role>
    <affiliation>Allergan PLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cabinet medical Solferino</name>
      <address>
        <city>Paris</city>
        <zip>75007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Chirurgie Esthetique</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hautzentrum Altenbochum - RuhrDERM Gemeinschaftspraxis Dr. med. Ardabili - Dr. med. Niesmann</name>
      <address>
        <city>Bochum</city>
        <zip>44803</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dermatolgie Köln am Rhein</name>
      <address>
        <city>Cologne</city>
        <zip>50996</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH</name>
      <address>
        <city>Darmstadt</city>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotes Kreuz Krankenhaus Kassel Gemeinnützige GmbH Klinik für Plastische, Rekonstruktive und Ästhetische Chirurgie</name>
      <address>
        <city>Kassel</city>
        <zip>34121</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxisgemeinschaft Theatiner46 Dres. Ogilvie und Dr. Bernd Schuster</name>
      <address>
        <city>Munich</city>
        <zip>80333</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dermatogische Privatpraxis CentroDerm GmbH</name>
      <address>
        <city>Wuppertal</city>
        <zip>42287</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniek Dokter Frodo Gaymans</name>
      <address>
        <city>Amsterdam</city>
        <zip>1075</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joost Kroon Cosmetische Kliniek</name>
      <address>
        <city>Amsterdam</city>
        <zip>1077</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <link>
    <url>http://www.allerganclinicaltrials.com</url>
    <description>More Information</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2015</study_first_submitted>
  <study_first_submitted_qc>September 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2015</study_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

